Skip to main content
SpringerLink
Log in

First deuterated drug approved

  • News
  • Published:

From Nature Biotechnology

View current issue Submit your manuscript

A Correction to this article was published on 09 November 2017

This article has been updated

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Change history

  • 13 April 2018

    In the version of this article initially published, the drug BMS-986165 was listed as a "deuterium-modified" version of rosuvastatin, rather than a "deuterium-modified" new molecular entity. The error has been corrected in the HTML and PDF versions of the article.

Author information

Authors and Affiliations

  1. Portland, Oregon

    Charles Schmidt

Authors
  1. Charles Schmidt
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Schmidt, C. First deuterated drug approved. Nat Biotechnol 35, 493–494 (2017). https://doi.org/10.1038/nbt0617-493

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0617-493

  • Springer Nature America, Inc.

This article is cited by

Search

Navigation